Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06001437 · ClinicalTrials.gov registry record

Following Outcomes Remotely Within Addiction Recovery Domains

A clinical trial of Opioid Use Disorder, sponsored by Mclean Hospital.

Recruiting
Registry status
1,600
Enrollment target
1
Study location

NCT06001437: Recruiting study of Opioid Use Disorder, sponsored by Mclean Hospital.

NCT06001437 is a study of Opioid Use Disorder that is actively recruiting participants, run by Mclean Hospital. The registered enrollment target is 1,600 participants, below the 4,650-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06001437, a study of Opioid Use Disorder, is actively recruiting participants, sponsored by Mclean Hospital.

RECRUITING
Registry status
1,600 participants
Enrollment target
1
Study location

Study Summary

The aim of this study is to describe outcome of people with opioid use disorder over the long-term by collecting monthly and yearly data on their recovery. Adults with opioid use disorder who participate will complete surveys monthly online and once per year by phone about their substance use, mental health, treatment involvement and functioning. The goal of this study is to better understand how people with opioid use disorder recover over time to improve intervention for this group.

Primary Outcome

Count of months of opioid use.

Conditions Studied

Study Locations (1)

Massachusetts

  • McLean Hospital - Belmont

Trial Details

FieldValue
Enrollment Target 1,600 participants
Start Date 2023-09-02
Est. Completion 2026-07
Mclean Hospital

140 total trials

What NCT06001437 shows while recruiting

NCT06001437 is an observational study that tracks outcomes without assigning an intervention. Its 1,600 participants enrollment target places it among the larger protocols in the corpus, below the 4,650-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (66% lower).

The record links to 1 condition, with Opioid Use Disorder appearing as the primary indexed condition, and to 0 interventions.

NCT06001437 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06001437 about?

NCT06001437 is a clinical study titled "Following Outcomes Remotely Within Addiction Recovery Domains". The aim of this study is to describe outcome of people with opioid use disorder over the long-term by collecting monthly and yearly data on their recovery. Adults with opioid use disorder who participate will complete surveys monthly online and once per year by phone about their substance use, menta...

What is the current status of trial NCT06001437?

This trial is currently recruiting. The enrollment target is 1,600 participants. The study started on 2023-09-02. Estimated completion is 2026-07.

What conditions does trial NCT06001437 study?

This clinical trial studies the following conditions: Opioid Use Disorder.

Who is sponsoring clinical trial NCT06001437?

This trial is sponsored by Mclean Hospital, which has 140 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06001437 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Opioid Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06001437's enrollment target sits among peer trials

1,600 13th of 257 higher than 245 of 257 other Opioid Use Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Opioid Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00646022 · 1,600 participants

    Natural History of Familial Carcinoid Tumor

  • NCT03109197 · 1,600 participants

    Sudden Unexplained Death in Childhood (SUDC) Registry

  • NCT03511118 · 1,600 participants

    Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants

  • NCT04314401 · 1,600 participants

    National Cancer Institute "Cancer Moonshot Biobank"

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06001437, the US trial registry maintained by the National Library of Medicine. NCT06001437 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.